Manager TitleAgeSince
Chief Executive Officer 86 01/09/2013
Director of Finance/CFO 54 01/10/2012
Director TitleAgeSince
Chairman 54 12/08/2021
Director/Board Member 45 -
Director/Board Member 54 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-38.68% - - 104K
-0.48%+8.75%-5.51%+0.91% 46.36B
+2.19%+9.81%+385.81%+632.13% 37.88B
+2.53%+13.90%+20.85%-10.61% 31.12B
+1.65%+2.98%+9.98%+55.42% 30.61B
-4.16%-4.44%+8.53%+16.06% 24.69B
-0.32%+14.36% - - 16.25B
+1.37%+15.67%+71.80%+134.14% 14.85B
+1.00%+9.67%+14.90%+21.88% 13.58B
+3.63%+6.97%+104.07%+107.62% 12.95B
Average +0.88%+7.85%+76.30%+119.69% 25.36B
Weighted average by Cap. +0.95%+7.66%+85.55%+138.80%

Financials

2020 2021
Net sales 1.5M 1.71M 1.38M 1.3M 2.43M 162M 2.48M 16.64M 6.44M 79.88M 6.43M 6.29M 277M 1.08M 1.23M 993K 930K 1.74M 116M 1.78M 11.93M 4.62M 57.27M 4.61M 4.51M 199M
Net income 14.75M 16.82M 13.59M 12.73M 23.86M 1.59B 24.36M 163M 63.22M 784M 63.15M 61.78M 2.72B -10.57M -12.06M -9.75M -9.13M -17.11M -1.14B -17.47M -117M -45.33M -562M -45.29M -44.3M -1.95B
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33